Exact Mass: 482.06700340000003
Exact Mass Matches: 482.06700340000003
Found 152 metabolites which its exact mass value is equals to given mass value 482.06700340000003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
3'-(2'-Galloylglucosyl)-phloroacetophenone
3-(2-Galloylglucosyl)-phloroacetophenone is found in herbs and spices. 3-(2-Galloylglucosyl)-phloroacetophenone is a constituent of Syzygium aromaticum (clove). Constituent of Syzygium aromaticum (clove). 3-(2-Galloylglucosyl)-phloroacetophenone is found in herbs and spices.
3,4,5,11,12,13,21,22,23-nonahydroxy-9,14,17-trioxatetracyclo[17.4.0.0(2),.0(1),(1)]tricosa-1(23),2,4,6,19,21-hexaene-8,18-dione
3'-(6'-Galloylglucosyl)-phloroacetophenone
3-(6-Galloylglucosyl)-phloroacetophenone is found in herbs and spices. 3-(6-Galloylglucosyl)-phloroacetophenone is a constituent of Syzygium aromaticum (clove). Constituent of Syzygium aromaticum (clove). 3-(6-Galloylglucosyl)-phloroacetophenone is found in herbs and spices.
6,7,8,11,12,13,21,22,23-nonahydroxy-2,17,20-trioxatetracyclo[17.3.1.0,.0(1),(1)]tricosa-4,6,8,10,12,14-hexaene-3,16-dione
(-)-Epigallocatechin 3'-glucuronide
(-)-Epigallocatechin 3-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
(-)-Epigallocatechin 3-glucuronide
(-)-Epigallocatechin 3-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
(-)-Epigallocatechin 7-glucuronide
(-)-Epigallocatechin 7-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
Regorafenib
C21H15ClF4N4O3 (482.07687580000004)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Regorafenib (BAY 73-4506) is an orally active and potent multi-targeted receptor tyrosine kinase inhibitor, with IC50 values of 13/4.2/46, 22, 7, 1.5 and 2.5 nM for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1, respectively. Regorafenib shows very robust antitumor and antiangiogenic activity[1].
Seletalisib
3,4,2,3,4,6,alpha-Heptahydroxychalcone 2-glucoside
2-(alpha-Hydroxypropyl)thiamine diphosphate; 2-Hydroxypropyl-ThPP
5,6,7,8,2,5-hexahydroxy-4-methoxyflavanone-beta-D-xylopyranoside
5-O-(6-galloyl)-beta-D-glucopyranosyl methyl gentisate|rubrumoside B
4,6-(S)-HHDP-D-glucose|4,6-O-((S)-4,4,5,5,6,6-hexahydroxydiphenoyl)-D-glucose|4,6-O-<(S)-4,4,5,5,6,6-hexahydroxydiphenoyl>-D-glucose
glucopyranosyl 2-O-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxyphenylacetate
Cys Cys Glu Glu
C16H26N4O9S2 (482.11411460000005)
Cys Asp Asp Met
C16H26N4O9S2 (482.11411460000005)
Cys Asp Met Asp
C16H26N4O9S2 (482.11411460000005)
Cys Glu Cys Glu
C16H26N4O9S2 (482.11411460000005)
Cys Glu Glu Cys
C16H26N4O9S2 (482.11411460000005)
Cys Met Asp Asp
C16H26N4O9S2 (482.11411460000005)
Asp Cys Asp Met
C16H26N4O9S2 (482.11411460000005)
Asp Cys Met Asp
C16H26N4O9S2 (482.11411460000005)
Asp Asp Cys Met
C16H26N4O9S2 (482.11411460000005)
Asp Asp Met Cys
C16H26N4O9S2 (482.11411460000005)
Asp Met Cys Asp
C16H26N4O9S2 (482.11411460000005)
Asp Met Asp Cys
C16H26N4O9S2 (482.11411460000005)
Glu Cys Cys Glu
C16H26N4O9S2 (482.11411460000005)
Glu Cys Glu Cys
C16H26N4O9S2 (482.11411460000005)
Glu Glu Cys Cys
C16H26N4O9S2 (482.11411460000005)
Met Cys Asp Asp
C16H26N4O9S2 (482.11411460000005)
Met Asp Cys Asp
C16H26N4O9S2 (482.11411460000005)
Met Asp Asp Cys
C16H26N4O9S2 (482.11411460000005)
3'-(2''-Galloylglucosyl)-phloroacetophenone
3'-(6''-Galloylglucosyl)-phloroacetophenone
(-)-Epigallocatechin 3'-glucuronide
(-)-Epigallocatechin 3-glucuronide
(-)-Epigallocatechin 7-glucuronide
2-(4-Iodophenyl)-4,5-bis(4-methoxyphenyl)-1H-imidazole
Ferrous gluconate dihydrate
B - Blood and blood forming organs > B03 - Antianemic preparations > B03A - Iron preparations > B03AA - Iron bivalent, oral preparations D006401 - Hematologic Agents > D006397 - Hematinics
2-Naphthalenesulfonic acid, 6-hydroxy-5-[2-(2-methoxy-5-methyl-4- sulfophenyl)diazenyl]-, aluminum salt (1:1)
Raltegravir potassium
D004791 - Enzyme Inhibitors > D019429 - Integrase Inhibitors > D019428 - HIV Integrase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent
4-[2-(4-carboxy-3-nitrophenyl)-1,1,1,3,3,3-hexafluoropropan-2-yl]-2-nitrobenzoic acid
C17H8F6N2O8 (482.01848399999994)
cis-[2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl-4-methylbenzenesulphonate
C21H20Cl2N2O5S (482.04699300000004)
[3,3,4,4,5,5,6,6,7,8,8,8-dodecafluoro-7-(trifluoromethyl)octyl] 2-methylprop-2-enoate
C13H9F15O2 (482.03629939999996)
2-(4-(2-((3-(5-(Pyridin-2-Ylthio)thiazol-2-Yl)ureido)methyl)-1h-Imidazol-4-Yl)phenoxy)acetic Acid
Regorafenib
C21H15ClF4N4O3 (482.07687580000004)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Regorafenib (BAY 73-4506) is an orally active and potent multi-targeted receptor tyrosine kinase inhibitor, with IC50 values of 13/4.2/46, 22, 7, 1.5 and 2.5 nM for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1, respectively. Regorafenib shows very robust antitumor and antiangiogenic activity[1].
2,3-Dihydroxybenzoyl 5-adenylate(1-)
C17H17N5O10P- (482.07130120000005)
Conjugate base of 2,3-dihydroxybenzoyl 5-adenylate.
(3,4-Dihydroxybenzoate)adenylate
C17H17N5O10P- (482.07130120000005)
2,6-dichloro-3-(glutathion-S-yl)-hydroquinone
C16H18Cl2N3O8S- (482.01916280000006)
[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 3-amino-4-hydroxybenzoate
2-[(2,6-dichlorophenyl)sulfonylamino]-3-methylbutanoic acid [2-(1H-indol-3-yl)-2-oxoethyl] ester
C21H20Cl2N2O5S (482.04699300000004)
(E)-2-cyano-N-(1,1-dioxothiolan-3-yl)-3-[2-(4-fluorophenoxy)-9-methyl-4-oxopyrido[1,2-a]pyrimidin-3-yl]prop-2-enamide
C23H19FN4O5S (482.10601360000004)
4-(4-chlorophenyl)sulfonyl-5-(3,4-dihydro-1H-isoquinolin-2-yl)-2-ethylsulfonylthiazole
C20H19ClN2O4S3 (482.0195444000001)
2-Phenyl-5-thiophen-2-yl-3-pyrazolecarboxylic acid [2-(4-chloro-3-nitroanilino)-2-oxoethyl] ester
C22H15ClN4O5S (482.04516500000005)
2-Phenyl-5-thiophen-2-yl-3-pyrazolecarboxylic acid [2-(2-chloro-5-nitroanilino)-2-oxoethyl] ester
C22H15ClN4O5S (482.04516500000005)
2-[1-(4-chlorophenyl)-5-oxo-3-(2-pyridin-4-ylethyl)-2-sulfanylidene-4-imidazolidinyl]-N-(4-fluorophenyl)acetamide
N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-5-(2-pyridinyl)-2-thiophenesulfonamide
C18H12F6N2O3S2 (482.01935139999995)
6-Bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(thiophen-2-ylthio)methyl]-3-indolecarboxylic acid ethyl ester
C20H23BrN2O3S2 (482.03333879999997)
N-[(3,4-dichlorophenyl)methyl]-2-[(2S,3R,6R)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(3,4-dichlorophenyl)methyl]-2-[(2S,3S,6R)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(3,4-dichlorophenyl)methyl]-2-[(2S,3S,6S)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(3,4-dichlorophenyl)methyl]-2-[(2R,3S,6S)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(3,4-dichlorophenyl)methyl]-2-[(2R,3S,6R)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(3,4-dichlorophenyl)methyl]-2-[(2R,3R,6S)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(3,4-dichlorophenyl)methyl]-2-[(2R,3R,6R)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
2-hydroxy-4-[4-[(5Z)-5-[(Z)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]benzoic acid
[2-[5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-4,5-dihydroxyoxan-3-yl] hydrogen sulate
[2-(acetyloxy)-2-(9-{[(2E)-2-methylbut-2-enoyl]oxy}-2-oxo-2H,8H,9H-furo[2,3-h]chromen-8-yl)propoxy]sulfonic acid
2-(2,5-dihydroxy-4-methoxyphenyl)-5,6,8-trihydroxy-7-[(3,4,5-trihydroxyoxan-2-yl)oxy]-2,3-dihydro-1-benzopyran-4-one
(7r,8s,8as)-8-hydroxy-7-methyl-6-oxo-3-[(1e)-prop-1-en-1-yl]-8,8a-dihydro-1h-isochromen-7-yl 3,5-dichloro-2,4-dimethoxy-6-methylbenzoate
7,7'-dihydroxy-3-[(2-oxochromen-7-yl)oxy]-[8,8'-bichromene]-2,2'-dione
(10r,11r,13r,14r,15s)-3,4,5,11,14,20,21,22-octahydroxy-13-(hydroxymethyl)-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(18),2,4,6,19,21-hexaene-8,17-dione
(10r,11s,13r,14r,15s)-3,4,5,11,14,20,21,22-octahydroxy-13-(hydroxymethyl)-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(18),2,4,6,19,21-hexaene-8,17-dione
2,3-hexahydroxydiphenyl-D-glucose
{"Ingredient_id": "HBIN004100","Ingredient_name": "2,3-hexahydroxydiphenyl-D-glucose","Alias": "NA","Ingredient_formula": "C20H18O14","Ingredient_Smile": "C1=C2C(=C(C(=C1O)O)O)C3=C(C(=C(C=C3C(=O)OC4C(C(C(OC4O)CO)O)OC2=O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42628","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2,3-o-(s)-hexahydroxydiphenoyl-d-gluco-pyranose
{"Ingredient_id": "HBIN004147","Ingredient_name": "2,3-o-(s)-hexahydroxydiphenoyl-d-gluco-pyranose","Alias": "NA","Ingredient_formula": "C20H18O14","Ingredient_Smile": "C1=C2C(=C(C(=C1O)O)O)C3=C(C(=C(C=C3C(=O)OC4C(C(C(OC4O)CO)O)OC2=O)O)O)O","Ingredient_weight": "482.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15749","TCMID_id": "9501","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "14035453","DrugBank_id": "NA"}
(10s,11r,12r,13r,15r)-3,4,5,11,12,13,21,22,23-nonahydroxy-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(19),2,4,6,20,22-hexaene-8,18-dione
(3r,11r)-3,11-bis(3,4-dihydroxyphenyl)-4,12-dioxapentacyclo[8.6.1.1²,⁵.0¹³,¹⁷.0⁹,¹⁸]octadeca-1,5(18),6,8,10(17),13,15-heptaene-7,15-diol
(2s)-2-(2,5-dihydroxy-4-methoxyphenyl)-5,6,8-trihydroxy-7-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-2,3-dihydro-1-benzopyran-4-one
3,5-dihydroxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-(3,4,5-trihydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one
5'-[2,4-dihydroxy-6-(2,4,6-trihydroxyphenoxy)phenoxy]-[1,1'-biphenyl]-2,3',4,6-tetrol
(2s,3r)-3,5-dihydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-(3,4,5-trihydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one
(2r,3r,4r,5r)-4,5,6-trihydroxy-1-oxo-2-[2-oxo-2-(3,4,5-trihydroxyphenyl)ethyl]hexan-3-yl 3,4,5-trihydroxybenzoate
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[3-hydroxy-4-(methoxycarbonyl)phenoxy]oxan-2-yl]methyl 3,4,5-trihydroxybenzoate
(2r)-2,3-dihydroxypropoxy((2s)-3-{[(2r,3r,4s,5s)-5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl]oxy}-2-hydroxypropoxy)phosphinic acid
C13H28AsO12P (482.05342780000007)
5,7-dihydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-(3,4,5-trihydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one
(2s,3r)-2-(3,4-dihydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-3,5,7-trihydroxy-2,3-dihydro-1-benzopyran-4-one
(2s)-2-{[(2r)-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-1-hydroxy-3-sulfanylpropylidene]amino}-4-{[(1r)-1-carboxy-2-sulfanylethyl]-c-hydroxycarbonimidoyl}butanoic acid
C16H26N4O9S2 (482.11411460000005)
[(6s,8as)-8a-(chloromethyl)-8-hydroxy-1-methyl-2,5-dioxo-3h,6h-imidazo[1,2-a]pyrazin-6-yl]methyl 2,3-dihydroxy-2-(hydroxymethyl)-1,4-benzoxazine-5-carboxylate
(2r,3r)-2,8-dihydroxy-6-{[(2r,3s,4s,5r,6r)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy}-3-(3,4,5-trihydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one
3,4,5,11,12,13,21,22,23-nonahydroxy-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(19),2,4,6,20,22-hexaene-8,18-dione
4-chloro-5-[2-chloro-4-(2-chloro-6-methylphenoxy)-3,5,6-trimethylphenoxy]-3-methoxybenzene-1,2-diol
C23H21Cl3O5 (482.04545060000004)
[(2r,3s,4s,5r,6s)-6-(2-acetyl-3,5-dihydroxyphenoxy)-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate
7'-hydroxy-7-[(7-hydroxy-2-oxochromen-3-yl)oxy]-[6,8'-bichromene]-2,2'-dione
5,7-dibromo-3a-(3,7-dimethylocta-2,6-dien-1-yl)-1-methyl-2h,3h,8h,8ah-pyrrolo[2,3-b]indol-4-ol
8-hydroxy-7-methyl-6-oxo-3-(prop-1-en-1-yl)-8,8a-dihydro-1h-isochromen-7-yl 3,5-dichloro-2,4-dimethoxy-6-methylbenzoate
3,4,5,11,14,20,21,22-octahydroxy-13-(hydroxymethyl)-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(22),2(7),3,5,18,20-hexaene-8,17-dione
(2r,3s)-5,7-dihydroxy-3-{[(2s,3r,4r,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-(3,4,5-trihydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one
[6-(2-acetyl-3,5-dihydroxyphenoxy)-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate
(1s,19r,21s,22r,23r)-6,7,8,11,12,13,21,22,23-nonahydroxy-2,17,20-trioxatetracyclo[17.3.1.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,6,8,10(15),11,13-hexaene-3,16-dione
(2s,3r)-5,7-dihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-(3,4,5-trihydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one
2,3-dihydroxypropoxy(3-({5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl}oxy)-2-hydroxypropoxy)phosphinic acid
C13H28AsO12P (482.05342780000007)
2,8-dihydroxy-6-[(3,4,5,6-tetrahydroxyoxan-2-yl)methoxy]-3-(3,4,5-trihydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one
7-hydroxy-7'-[(7-hydroxy-2-oxochromen-3-yl)oxy]-[6,8'-bichromene]-2,2'-dione
2-(3,4-dihydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-3,5,7-trihydroxy-2,3-dihydro-1-benzopyran-4-one
(2r,3r)-2-(3,4-dihydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-3,5,7-trihydroxy-2,3-dihydro-1-benzopyran-4-one
(14s,15r,19r)-2,3,4,7,8,9,19-heptahydroxy-14-[(1r,2r)-1,2,3-trihydroxypropyl]-13,16-dioxatetracyclo[13.3.1.0⁵,¹⁸.0⁶,¹¹]nonadeca-1,3,5(18),6(11),7,9-hexaene-12,17-dione
2,3,4,7,8,9,19-heptahydroxy-14-(1,2,3-trihydroxypropyl)-13,16-dioxatetracyclo[13.3.1.0⁵,¹⁸.0⁶,¹¹]nonadeca-1,3,5(18),6(11),7,9-hexaene-12,17-dione
2-amino-4-{[1-({1-carboxy-3-[(1-carboxy-2-sulfanylethyl)-c-hydroxycarbonimidoyl]propyl}-c-hydroxycarbonimidoyl)-2-sulfanylethyl]-c-hydroxycarbonimidoyl}butanoic acid
C16H26N4O9S2 (482.11411460000005)